⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRTC News
PureTech Health plc American Depositary Shares
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo ™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
businesswire.com
PRTC
Particula Launches the Digital Asset Risk Passport (PDARP) - Programmable Risk Infrastructure for Onchain Capital Markets
globenewswire.com
PRTC
proteanTecs、TOPPANグループのコーポレートベンチャーであるTGVPより戦略的投資を獲得
businesswire.com
PRTC
PureTech to Present at the Leerink Partners Global Healthcare Conference
businesswire.com
PRTC
proteanTecs 与孤波科技强强联手，为先进半导体系统提供统一分析解决方案
businesswire.com
PRTC
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
businesswire.com
PRTC
PureTech to Present at 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
PRTC
PureTech Appoints Robert Lyne as Chief Executive Officer
businesswire.com
PRTC
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
businesswire.com
PRTC